BIOSCIENCE HEALTH INNOVATIONS INC. Research and Development Expense
BIOSCIENCE HEALTH INNOVATIONS INC. (BHIC) reported Research and Development Expense of $120.31 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-07
- BIOSCIENCE HEALTH INNOVATIONS INC. research and development expense for the quarter ending 2026-06-30 was $70.58K, a 663.65% increase year-over-year.
- BIOSCIENCE HEALTH INNOVATIONS INC. research and development expense for the quarter ending 2026-03-31 was $49.72K, a 32.45% increase year-over-year.
- BIOSCIENCE HEALTH INNOVATIONS INC. research and development expense for the quarter ending 2025-12-31 was -$28.83K.
- BIOSCIENCE HEALTH INNOVATIONS INC. research and development expense for the quarter ending 2025-09-30 was $19.59K, a 24.70% decline year-over-year.
- BIOSCIENCE HEALTH INNOVATIONS INC. research and development expense for fiscal 2024 was $25.91K.
- BIOSCIENCE HEALTH INNOVATIONS INC. research and development expense for fiscal 2023 was $0.00.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $70.58K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $120.31K 10-Q · filed 2026-08-07 | $91.47K derived: sum of 3 quarters · filed 2026-08-07 | $111.06K derived: sum of 4 quarters · filed 2026-08-07 | |
| 2026-03-31 | $49.72K 10-Q · filed 2026-05-11 | $20.89K derived: sum of 2 quarters · filed 2026-05-11 | $40.48K derived: sum of 3 quarters · filed 2026-05-11 | $49.72K derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-12-31 | -$28.83K derived: 10-Q 12 month − 10-Q 9 month · filed 2026-05-11 | -$9.24K derived: sum of 2 quarters · filed 2026-05-11 | $0.00 derived: sum of 3 quarters · filed 2026-08-07 | $37.54K 10-Q · filed 2026-05-11 | $161.35K 10-K · filed 2026-03-30 |
| 2025-09-30 | $19.59K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-27 | $28.83K derived: sum of 2 quarters · filed 2026-08-07 | $66.37K 10-Q · filed 2025-10-27 | $62.47K derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-06-30 | $9.24K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $46.78K 10-Q · filed 2026-08-07 | $42.88K derived: sum of 3 quarters · filed 2026-08-07 | $68.90K derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-03-31 | $37.54K 10-Q · filed 2025-05-08 | $33.64K derived: sum of 2 quarters · filed 2026-03-30 | $59.65K derived: sum of 3 quarters · filed 2026-03-30 | $62.64K derived: sum of 4 quarters · filed 2026-03-30 | |
| 2024-12-31 | -$3.90K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $22.11K derived: sum of 2 quarters · filed 2026-03-30 | $25.10K derived: sum of 3 quarters · filed 2026-03-30 | $25.91K 10-K · filed 2026-03-30 | |
| 2024-09-30 | $26.01K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-27 | $29.00K derived: sum of 2 quarters · filed 2025-10-27 | $29.81K 10-Q · filed 2025-10-27 | $29.81K derived: sum of 4 quarters · filed 2025-10-27 | |
| 2024-06-30 | $2.99K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $3.79K 10-Q · filed 2025-08-07 | $3.79K derived: sum of 3 quarters · filed 2025-08-07 | ||
| 2024-03-31 | $805.00 10-Q · filed 2025-05-08 | $805.00 derived: sum of 2 quarters · filed 2025-05-08 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $0.00 10-K · filed 2025-03-13 | |||
| 2023-09-30 | $0.00 10-Q · filed 2024-10-28 |